Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(1.41)
# 1491
Out of 5,305 analysts
102
Total ratings
50.88%
Success rate
5.30%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
BMRN Biomarin Pharmaceuti... | Reiterates: Overweight | 90 90 | 63.26 | 42.27% | 15 | Feb 20, 2025 | |
VRTX Vertex Pharmaceutica... | Reiterates: Overweight | 480 480 | 493.96 | -2.83% | 22 | Feb 11, 2025 | |
BMY Bristol-Myers Squibb | Maintains: Neutral | 50 55 | 47.83 | 14.99% | 9 | Feb 4, 2025 | |
GILD Gilead Sciences | Reiterates: Neutral | 80 80 | 103.19 | -22.47% | 10 | Dec 11, 2024 | |
OMER Omeros | Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 602.46 | 68.48% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 280.72 | 44.27% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 251.72 | -12.6% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 8.17 | 22.4% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 4.74 | 37.13% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 38.31 | 87.94% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | n/a | n/a | 2 | Feb 23, 2023 |